SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-22-010479
Filing Date
2022-03-15
Accepted
2022-03-15 17:30:45
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 acet-s3.htm S-3 535683
2 EX-4.3 acet-ex43_66.htm EX-4.3 518374
3 EX-4.4 acet-ex44_65.htm EX-4.4 525375
4 EX-5.1 acet-ex51_86.htm EX-5.1 26964
5 EX-23.1 acet-ex231_63.htm EX-23.1 1887
6 EX-FILING FEES acet-exfilingfees_64.htm EX-FILING FEES 155649
7 GRAPHIC gpktgg3ggvlx000001.jpg GRAPHIC 27779
8 GRAPHIC gvo3im4l0ujg000001.jpg GRAPHIC 5234
9 GRAPHIC g2id5kvnfs4h000001.jpg GRAPHIC 5234
  Complete submission text file 0001564590-22-010479.txt   1818152
Mailing Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116
Business Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-263587 | Film No.: 22742434
SIC: 2834 Pharmaceutical Preparations